APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oseltamivir

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Oseltamivir Market Analysis and Forecast 2026-2032

22 December 2025199 pages

Choose your research edition.

Industry ResearchOseltamivir Industry Research Report 2026108 pages · $2,950 USDIndustry Growth & TrendsGlobal Oseltamivir Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Oseltamivir Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oseltamivir Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Oseltamivir Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Oseltamivir market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Oseltamivir is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Oseltamivir is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Oseltamivir is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Oseltamivir is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Oseltamivir include Roche. etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Oseltamivir, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Oseltamivir, also provides the sales of main regions and countries. Of the upcoming market potential for Oseltamivir, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Oseltamivir sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Oseltamivir market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Oseltamivir sales, projected growth trends, production technology, application and end-user industry.

Oseltamivir Segment by Company

Roche

Oseltamivir Segment by Type

Capsule

Oral Solution

Oseltamivir Segment by Application

Influenza A

Influenza B

Oseltamivir Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oseltamivir market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oseltamivir and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oseltamivir.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Oseltamivir in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Oseltamivir manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oseltamivir sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Oseltamivir Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Capsule Major Manufacturers Table 3. Oral Solution Major Manufacturers Table 4. Global Oseltamivir Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Influenza A Major Manufacturers Table 6. Influenza B Major Manufacturers Table 7. Oseltamivir Industry Trends Table 8. Oseltamivir Industry Drivers Table 9. Oseltamivir Industry Opportunities and Challenges Table 10. Oseltamivir Industry Restraints Table 11. Global Oseltamivir Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Oseltamivir Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Oseltamivir Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Oseltamivir Revenue Market Share by Region (2021-2026) Table 15. Global Oseltamivir Revenue Market Share by Region (2027-2032) Table 16. Global Oseltamivir Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 17. Global Oseltamivir Sales by Region (2021-2026) & (k units) Table 18. Global Oseltamivir Sales by Region (2027-2032) & (k units) Table 19. Global Oseltamivir Sales Market Share by Region (2021-2026) Table 20. Global Oseltamivir Sales Market Share by Region (2027-2032) Table 21. Global Oseltamivir Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Oseltamivir Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Oseltamivir Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Oseltamivir Sales Market Share by Manufacturers (2021-2026) Table 25. Global Oseltamivir Sales Price (US$/unit) of Manufacturers (2021-2026) Table 26. Global Oseltamivir Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Oseltamivir Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Oseltamivir Manufacturers, Product Type & Application Table 29. Global Oseltamivir Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Oseltamivir by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Oseltamivir Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Oseltamivir Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Oseltamivir Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Oseltamivir Revenue Market Share by Type (2021-2026) Table 36. Global Oseltamivir Revenue Market Share by Type (2027-2032) Table 37. Global Oseltamivir Sales by Type 2021 VS 2025 VS 2032 (k units) Table 38. Global Oseltamivir Sales by Type (2021-2026) & (k units) Table 39. Global Oseltamivir Sales by Type (2027-2032) & (k units) Table 40. Global Oseltamivir Sales Market Share by Type (2021-2026) Table 41. Global Oseltamivir Sales Market Share by Type (2027-2032) Table 42. Global Oseltamivir Price by Type (2021-2026) & (US$/unit) Table 43. Global Oseltamivir Price by Type (2027-2032) & (US$/unit) Table 44. Global Oseltamivir Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Oseltamivir Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Oseltamivir Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Oseltamivir Revenue Market Share by Application (2021-2026) Table 48. Global Oseltamivir Revenue Market Share by Application (2027-2032) Table 49. Global Oseltamivir Sales by Application 2021 VS 2025 VS 2032 (k units) Table 50. Global Oseltamivir Sales by Application (2021-2026) & (k units) Table 51. Global Oseltamivir Sales by Application (2027-2032) & (k units) Table 52. Global Oseltamivir Sales Market Share by Application (2021-2026) Table 53. Global Oseltamivir Sales Market Share by Application (2027-2032) Table 54. Global Oseltamivir Price by Application (2021-2026) & (US$/unit) Table 55. Global Oseltamivir Price by Application (2027-2032) & (US$/unit) Table 56. Roche Company Information Table 57. Roche Business Overview Table 58. Roche Oseltamivir Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 59. Roche Oseltamivir Product Portfolio Table 60. Roche Recent Development Table 61. North America Oseltamivir Revenue by Type (2021-2026) & (US$ Million) Table 62. North America Oseltamivir Revenue by Type (2027-2032) & (US$ Million) Table 63. North America Oseltamivir Sales by Type (2021-2026) & (k units) Table 64. North America Oseltamivir Sales by Type (2027-2032) & (k units) Table 65. North America Oseltamivir Sales Price by Type (2021-2026) & (US$/unit) Table 66. North America Oseltamivir Sales Price by Type (2027-2032) & (US$/unit) Table 67. North America Oseltamivir Revenue by Application (2021-2026) & (US$ Million) Table 68. North America Oseltamivir Revenue by Application (2027-2032) & (US$ Million) Table 69. North America Oseltamivir Sales by Application (2021-2026) & (k units) Table 70. North America Oseltamivir Sales by Application (2027-2032) & (k units) Table 71. North America Oseltamivir Sales Price by Application (2021-2026) & (US$/unit) Table 72. North America Oseltamivir Sales Price by Application (2027-2032) & (US$/unit) Table 73. North America Oseltamivir Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 74. North America Oseltamivir Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 75. North America Oseltamivir Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 76. North America Oseltamivir Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 77. North America Oseltamivir Sales by Country (2021-2026) & (k units) Table 78. North America Oseltamivir Sales by Country (2027-2032) & (k units) Table 79. North America Oseltamivir Sales Price by Country (2021-2026) & (US$/unit) Table 80. North America Oseltamivir Sales Price by Country (2027-2032) & (US$/unit) Table 81. United States Oseltamivir Revenue (2021-2032) & (US$ Million) Table 82. Canada Oseltamivir Revenue (2021-2032) & (US$ Million) Table 83. Mexico Oseltamivir Revenue (2021-2032) & (US$ Million) Table 84. Europe Oseltamivir Revenue by Type (2021-2026) & (US$ Million) Table 85. Europe Oseltamivir Revenue by Type (2027-2032) & (US$ Million) Table 86. Europe Oseltamivir Sales by Type (2021-2026) & (k units) Table 87. Europe Oseltamivir Sales by Type (2027-2032) & (k units) Table 88. Europe Oseltamivir Sales Price by Type (2021-2026) & (US$/unit) Table 89. Europe Oseltamivir Sales Price by Type (2027-2032) & (US$/unit) Table 90. Europe Oseltamivir Revenue by Application (2021-2026) & (US$ Million) Table 91. Europe Oseltamivir Revenue by Application (2027-2032) & (US$ Million) Table 92. Europe Oseltamivir Sales by Application (2021-2026) & (k units) Table 93. Europe Oseltamivir Sales by Application (2027-2032) & (k units) Table 94. Europe Oseltamivir Sales Price by Application (2021-2026) & (US$/unit) Table 95. Europe Oseltamivir Sales Price by Application (2027-2032) & (US$/unit) Table 96. Europe Oseltamivir Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. Europe Oseltamivir Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 98. Europe Oseltamivir Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 99. Europe Oseltamivir Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 100. Europe Oseltamivir Sales by Country (2021-2026) & (k units) Table 101. Europe Oseltamivir Sales by Country (2027-2032) & (k units) Table 102. Europe Oseltamivir Sales Price by Country (2021-2026) & (US$/unit) Table 103. Europe Oseltamivir Sales Price by Country (2027-2032) & (US$/unit) Table 104. Germany Oseltamivir Revenue (2021-2032) & (US$ Million) Table 105. France Oseltamivir Revenue (2021-2032) & (US$ Million) Table 106. U.K. Oseltamivir Revenue (2021-2032) & (US$ Million) Table 107. Italy Oseltamivir Revenue (2021-2032) & (US$ Million) Table 108. Russia Oseltamivir Revenue (2021-2032) & (US$ Million) Table 109. Spain Oseltamivir Revenue (2021-2032) & (US$ Million) Table 110. Netherlands Oseltamivir Revenue (2021-2032) & (US$ Million) Table 111. Switzerland Oseltamivir Revenue (2021-2032) & (US$ Million) Table 112. Sweden Oseltamivir Revenue (2021-2032) & (US$ Million) Table 113. Poland Oseltamivir Revenue (2021-2032) & (US$ Million) Table 114. China Oseltamivir Revenue by Type (2021-2026) & (US$ Million) Table 115. China Oseltamivir Revenue by Type (2027-2032) & (US$ Million) Table 116. China Oseltamivir Sales by Type (2021-2026) & (k units) Table 117. China Oseltamivir Sales by Type (2027-2032) & (k units) Table 118. China Oseltamivir Sales Price by Type (2021-2026) & (US$/unit) Table 119. China Oseltamivir Sales Price by Type (2027-2032) & (US$/unit) Table 120. China Oseltamivir Revenue by Application (2021-2026) & (US$ Million) Table 121. China Oseltamivir Revenue by Application (2027-2032) & (US$ Million) Table 122. China Oseltamivir Sales by Application (2021-2026) & (k units) Table 123. China Oseltamivir Sales by Application (2027-2032) & (k units) Table 124. China Oseltamivir Sales Price by Application (2021-2026) & (US$/unit) Table 125. China Oseltamivir Sales Price by Application (2027-2032) & (US$/unit) Table 126. Asia Oseltamivir Revenue by Type (2021-2026) & (US$ Million) Table 127. Asia Oseltamivir Revenue by Type (2027-2032) & (US$ Million) Table 128. Asia Oseltamivir Sales by Type (2021-2026) & (k units) Table 129. Asia Oseltamivir Sales by Type (2027-2032) & (k units) Table 130. Asia Oseltamivir Sales Price by Type (2021-2026) & (US$/unit) Table 131. Asia Oseltamivir Sales Price by Type (2027-2032) & (US$/unit) Table 132. Asia Oseltamivir Revenue by Application (2021-2026) & (US$ Million) Table 133. Asia Oseltamivir Revenue by Application (2027-2032) & (US$ Million) Table 134. Asia Oseltamivir Sales by Application (2021-2026) & (k units) Table 135. Asia Oseltamivir Sales by Application (2027-2032) & (k units) Table 136. Asia Oseltamivir Sales Price by Application (2021-2026) & (US$/unit) Table 137. Asia Oseltamivir Sales Price by Application (2027-2032) & (US$/unit) Table 138. Asia Oseltamivir Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Asia Oseltamivir Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 140. Asia Oseltamivir Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 141. Asia Oseltamivir Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 142. Asia Oseltamivir Sales by Country (2021-2026) & (k units) Table 143. Asia Oseltamivir Sales by Country (2027-2032) & (k units) Table 144. Asia Oseltamivir Sales Price by Country (2021-2026) & (US$/unit) Table 145. Asia Oseltamivir Sales Price by Country (2027-2032) & (US$/unit) Table 146. Japan Oseltamivir Revenue (2021-2032) & (US$ Million) Table 147. South Korea Oseltamivir Revenue (2021-2032) & (US$ Million) Table 148. India Oseltamivir Revenue (2021-2032) & (US$ Million) Table 149. Australia Oseltamivir Revenue (2021-2032) & (US$ Million) Table 150. Taiwan Oseltamivir Revenue (2021-2032) & (US$ Million) Table 151. Southeast Asia Oseltamivir Revenue (2021-2032) & (US$ Million) Table 152. SAMEA Oseltamivir Revenue by Type (2021-2026) & (US$ Million) Table 153. SAMEA Oseltamivir Revenue by Type (2027-2032) & (US$ Million) Table 154. SAMEA Oseltamivir Sales by Type (2021-2026) & (k units) Table 155. SAMEA Oseltamivir Sales by Type (2027-2032) & (k units) Table 156. SAMEA Oseltamivir Sales Price by Type (2021-2026) & (US$/unit) Table 157. SAMEA Oseltamivir Sales Price by Type (2027-2032) & (US$/unit) Table 158. SAMEA Oseltamivir Revenue by Application (2021-2026) & (US$ Million) Table 159. SAMEA Oseltamivir Revenue by Application (2027-2032) & (US$ Million) Table 160. SAMEA Oseltamivir Sales by Application (2021-2026) & (k units) Table 161. SAMEA Oseltamivir Sales by Application (2027-2032) & (k units) Table 162. SAMEA Oseltamivir Sales Price by Application (2021-2026) & (US$/unit) Table 163. SAMEA Oseltamivir Sales Price by Application (2027-2032) & (US$/unit) Table 164. SAMEA Oseltamivir Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. SAMEA Oseltamivir Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 166. SAMEA Oseltamivir Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 167. SAMEA Oseltamivir Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 168. SAMEA Oseltamivir Sales by Country (2021-2026) & (k units) Table 169. SAMEA Oseltamivir Sales by Country (2027-2032) & (k units) Table 170. SAMEA Oseltamivir Sales Price by Country (2021-2026) & (US$/unit) Table 171. SAMEA Oseltamivir Sales Price by Country (2027-2032) & (US$/unit) Table 172. Brazil Oseltamivir Revenue (2021-2032) & (US$ Million) Table 173. Argentina Oseltamivir Revenue (2021-2032) & (US$ Million) Table 174. Chile Oseltamivir Revenue (2021-2032) & (US$ Million) Table 175. Colombia Oseltamivir Revenue (2021-2032) & (US$ Million) Table 176. Peru Oseltamivir Revenue (2021-2032) & (US$ Million) Table 177. Saudi Arabia Oseltamivir Revenue (2021-2032) & (US$ Million) Table 178. Israel Oseltamivir Revenue (2021-2032) & (US$ Million) Table 179. UAE Oseltamivir Revenue (2021-2032) & (US$ Million) Table 180. Turkey Oseltamivir Revenue (2021-2032) & (US$ Million) Table 181. Iran Oseltamivir Revenue (2021-2032) & (US$ Million) Table 182. Egypt Oseltamivir Revenue (2021-2032) & (US$ Million) Table 183. Key Raw Materials Table 184. Raw Materials Key Suppliers Table 185. Oseltamivir Distributors List Table 186. Oseltamivir Customers List Table 187. Research Programs/Design for This Report Table 188. Authors List of This Report Table 189. Secondary Sources Table 190. Primary Sources List of Figures Figure 1. Oseltamivir Image Figure 2. Global Oseltamivir Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oseltamivir Market Size Share 2021 VS 2025 VS 2032 Figure 4. Capsule Image Figure 5. Oral Solution Image Figure 6. Global Oseltamivir Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Oseltamivir Market Size Share 2021 VS 2025 VS 2032 Figure 8. Influenza A Image Figure 9. Influenza B Image Figure 10. Global Oseltamivir Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Oseltamivir Revenue (2021-2032) & (US$ Million) Figure 12. Global Oseltamivir Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Oseltamivir Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Oseltamivir Revenue Market Share by Region (2021-2032) Figure 15. Global Oseltamivir Sales (2021-2032) & (k units) Figure 16. Global Oseltamivir Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 17. Global Oseltamivir Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Oseltamivir Sales YoY (2021-2032) & (k units) Figure 19. Europe Oseltamivir Sales YoY (2021-2032) & (k units) Figure 20. China Oseltamivir Sales YoY (2021-2032) & (k units) Figure 21. Asia (Excluding China) Oseltamivir Sales YoY (2021-2032) & (k units) Figure 22. South America, Middle East and Africa Oseltamivir Sales YoY (2021-2032) & (k units) Figure 23. Global Oseltamivir Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Oseltamivir Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Oseltamivir Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Oseltamivir Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Oseltamivir Revenue Market Share by Type (2021-2032) Figure 29. Global Oseltamivir Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 30. Global Oseltamivir Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Oseltamivir Sales Market Share by Type (2021-2032) Figure 32. Global Oseltamivir Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Oseltamivir Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Oseltamivir Revenue Market Share by Application (2021-2032) Figure 35. Global Oseltamivir Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 36. Global Oseltamivir Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Oseltamivir Sales Market Share by Application (2021-2032) Figure 38. North America Oseltamivir Revenue Share by Type (2021-2032) Figure 39. North America Oseltamivir Sales Share by Type (2021-2032) Figure 40. North America Oseltamivir Revenue Share by Application (2021-2032) Figure 41. North America Oseltamivir Sales Share by Application (2021-2032) Figure 42. North America Oseltamivir Revenue Share by Country (2021-2032) Figure 43. North America Oseltamivir Sales Share by Country (2021-2032) Figure 44. Europe Oseltamivir Revenue Share by Type (2021-2032) Figure 45. Europe Oseltamivir Sales Share by Type (2021-2032) Figure 46. Europe Oseltamivir Revenue Share by Application (2021-2032) Figure 47. Europe Oseltamivir Sales Share by Application (2021-2032) Figure 48. Europe Oseltamivir Revenue Share by Country (2021-2032) Figure 49. Europe Oseltamivir Sales Share by Country (2021-2032) Figure 50. China Oseltamivir Revenue Share by Type (2021-2032) Figure 51. China Oseltamivir Sales Share by Type (2021-2032) Figure 52. China Oseltamivir Revenue Share by Application (2021-2032) Figure 53. China Oseltamivir Sales Share by Application (2021-2032) Figure 54. Asia Oseltamivir Revenue Share by Type (2021-2032) Figure 55. Asia Oseltamivir Sales Share by Type (2021-2032) Figure 56. Asia Oseltamivir Revenue Share by Application (2021-2032) Figure 57. Asia Oseltamivir Sales Share by Application (2021-2032) Figure 58. Asia Oseltamivir Revenue Share by Country (2021-2032) Figure 59. Asia Oseltamivir Sales Share by Country (2021-2032) Figure 60. SAMEA Oseltamivir Revenue Share by Type (2021-2032) Figure 61. SAMEA Oseltamivir Sales Share by Type (2021-2032) Figure 62. SAMEA Oseltamivir Revenue Share by Application (2021-2032) Figure 63. SAMEA Oseltamivir Sales Share by Application (2021-2032) Figure 64. SAMEA Oseltamivir Revenue Share by Country (2021-2032) Figure 65. SAMEA Oseltamivir Sales Share by Country (2021-2032) Figure 66. Oseltamivir Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Oseltamivir Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Capsule
  • Oral Solution
Applications
  • Influenza A
  • Influenza B
Companies covered
  • Roche

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Oseltamivir Market by Type
  3. 1.2.1 Global Oseltamivir Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Capsule
  5. 1.2.3 Oral Solution
  6. 1.3 Oseltamivir Market by Application
  7. 1.3.1 Global Oseltamivir Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Influenza A
  9. 1.3.3 Influenza B
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Oseltamivir Market Dynamics
  1. 2.1 Oseltamivir Industry Trends
  2. 2.2 Oseltamivir Industry Drivers
  3. 2.3 Oseltamivir Industry Opportunities and Challenges
  4. 2.4 Oseltamivir Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Oseltamivir Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Oseltamivir Revenue by Region
  3. 3.2.1 Global Oseltamivir Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Oseltamivir Revenue by Region (2021-2026)
  5. 3.2.3 Global Oseltamivir Revenue by Region (2027-2032)
  6. 3.2.4 Global Oseltamivir Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Oseltamivir Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Oseltamivir Sales by Region
  9. 3.4.1 Global Oseltamivir Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Oseltamivir Sales by Region (2021-2026)
  11. 3.4.3 Global Oseltamivir Sales by Region (2027-2032)
  12. 3.4.4 Global Oseltamivir Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Oseltamivir Revenue by Manufacturers
  2. 4.1.1 Global Oseltamivir Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Oseltamivir Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Oseltamivir Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Oseltamivir Sales by Manufacturers
  6. 4.2.1 Global Oseltamivir Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Oseltamivir Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Oseltamivir Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Oseltamivir Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Oseltamivir Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Oseltamivir Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Oseltamivir Manufacturers, Product Type & Application
  13. 4.7 Global Oseltamivir Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Oseltamivir Market CR5 and HHI
  16. 4.8.2 2025 Oseltamivir Tier 1, Tier 2, and Tier 3
5 Oseltamivir Market by Type
  1. 5.1 Global Oseltamivir Revenue by Type
  2. 5.1.1 Global Oseltamivir Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Oseltamivir Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Oseltamivir Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Oseltamivir Sales by Type
  6. 5.2.1 Global Oseltamivir Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Oseltamivir Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Oseltamivir Sales Market Share by Type (2021-2032)
  9. 5.3 Global Oseltamivir Price by Type
6 Oseltamivir Market by Application
  1. 6.1 Global Oseltamivir Revenue by Application
  2. 6.1.1 Global Oseltamivir Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Oseltamivir Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Oseltamivir Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Oseltamivir Sales by Application
  6. 6.2.1 Global Oseltamivir Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Oseltamivir Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Oseltamivir Sales Market Share by Application (2021-2032)
  9. 6.3 Global Oseltamivir Price by Application
7 Company Profiles
  1. 7.1 Roche
  2. 7.1.1 Roche Company Information
  3. 7.1.2 Roche Business Overview
  4. 7.1.3 Roche Oseltamivir Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Roche Oseltamivir Product Portfolio
  6. 7.1.5 Roche Recent Developments
8 North America
  1. 8.1 North America Oseltamivir Market Size by Type
  2. 8.1.1 North America Oseltamivir Revenue by Type (2021-2032)
  3. 8.1.2 North America Oseltamivir Sales by Type (2021-2032)
  4. 8.1.3 North America Oseltamivir Price by Type (2021-2032)
  5. 8.2 North America Oseltamivir Market Size by Application
  6. 8.2.1 North America Oseltamivir Revenue by Application (2021-2032)
  7. 8.2.2 North America Oseltamivir Sales by Application (2021-2032)
  8. 8.2.3 North America Oseltamivir Price by Application (2021-2032)
  9. 8.3 North America Oseltamivir Market Size by Country
  10. 8.3.1 North America Oseltamivir Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Oseltamivir Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Oseltamivir Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Oseltamivir Market Size by Type
  2. 9.1.1 Europe Oseltamivir Revenue by Type (2021-2032)
  3. 9.1.2 Europe Oseltamivir Sales by Type (2021-2032)
  4. 9.1.3 Europe Oseltamivir Price by Type (2021-2032)
  5. 9.2 Europe Oseltamivir Market Size by Application
  6. 9.2.1 Europe Oseltamivir Revenue by Application (2021-2032)
  7. 9.2.2 Europe Oseltamivir Sales by Application (2021-2032)
  8. 9.2.3 Europe Oseltamivir Price by Application (2021-2032)
  9. 9.3 Europe Oseltamivir Market Size by Country
  10. 9.3.1 Europe Oseltamivir Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Oseltamivir Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Oseltamivir Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Oseltamivir Market Size by Type
  2. 10.1.1 China Oseltamivir Revenue by Type (2021-2032)
  3. 10.1.2 China Oseltamivir Sales by Type (2021-2032)
  4. 10.1.3 China Oseltamivir Price by Type (2021-2032)
  5. 10.2 China Oseltamivir Market Size by Application
  6. 10.2.1 China Oseltamivir Revenue by Application (2021-2032)
  7. 10.2.2 China Oseltamivir Sales by Application (2021-2032)
  8. 10.2.3 China Oseltamivir Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Oseltamivir Market Size by Type
  2. 11.1.1 Asia Oseltamivir Revenue by Type (2021-2032)
  3. 11.1.2 Asia Oseltamivir Sales by Type (2021-2032)
  4. 11.1.3 Asia Oseltamivir Price by Type (2021-2032)
  5. 11.2 Asia Oseltamivir Market Size by Application
  6. 11.2.1 Asia Oseltamivir Revenue by Application (2021-2032)
  7. 11.2.2 Asia Oseltamivir Sales by Application (2021-2032)
  8. 11.2.3 Asia Oseltamivir Price by Application (2021-2032)
  9. 11.3 Asia Oseltamivir Market Size by Country
  10. 11.3.1 Asia Oseltamivir Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Oseltamivir Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Oseltamivir Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Oseltamivir Market Size by Type
  2. 12.1.1 SAMEA Oseltamivir Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Oseltamivir Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Oseltamivir Price by Type (2021-2032)
  5. 12.2 SAMEA Oseltamivir Market Size by Application
  6. 12.2.1 SAMEA Oseltamivir Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Oseltamivir Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Oseltamivir Price by Application (2021-2032)
  9. 12.3 SAMEA Oseltamivir Market Size by Country
  10. 12.3.1 SAMEA Oseltamivir Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Oseltamivir Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Oseltamivir Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Oseltamivir Value Chain Analysis
  2. 13.1.1 Oseltamivir Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Oseltamivir Production Mode & Process
  6. 13.2 Oseltamivir Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Oseltamivir Distributors
  9. 13.2.3 Oseltamivir Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst